Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation

Won‐Keun Kim MD, Fabien Praz MD, Johannes Blumenstein MD, Christoph Liebetrau MD, Luise Gaede MD, Arnaud Van Linden MD, Christian Hamm MD, PhD, Thomas Walther MD, PhD, Stephan Windecker MD, PhD, Helge Möllmann MD, PhD

Objectives: The purpose of the present study was to investigate whether transfemoral implantation of the balloon‐expandable Edwards SAPIEN 3 device without prior balloon valvuloplasty is feasible.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Off‐label use of the amplatzer ductal occluder II additional size for percutaneous treatment of acute aortic occlusion in a baby

G. Ferraro MD, D. Marini MD, G. Agnoletti MD, PhD

We describe the case of a 5‐month‐old baby with a pro‐coagulative condition, referred for rapid atrial tachycardia. At echocardiography we found a large free‐floating atrial thrombus that spontaneously embolized into the descending aorta and produced acute sub‐renal occlusion. Aorta and iliac vessels were cleared using the ADO II additional sizes device. © 2016 Wiley Periodicals, Inc.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: Results of the surgery after stenting registry

Roberta Rossini MD, PhD, Dominick J. Angiolillo MD, PhD, Giuseppe Musumeci MD, Davide Capodanno MD, PhD, Maddalena Lettino MD, Daniela Trabattoni MD, Annarita Pilleri MD, Paolo Calabria MD, Paola Colombo MD, PhD, Paola Bernabò MD, Marco Ferlini MD, Marco Ferri MD, Giuseppe Tarantini MD, PhD, Stefano De Servi MD, Stefano Savonitto MD

Objectives: The aim of the present study was to define the feasibility and clinical impact of complying with national consensus recommendations on perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and noncardiac surgery.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention

Mauro Carlino MD, Lorenzo Azzalini MD, PhD, MSc, Antonio Colombo MD

Background: Although the retrograde approach has improved the success rate and procedural efficiency of chronic total occlusion (CTO) percutaneous coronary intervention (PCI), it can still be challenging and time‐consuming. We introduce a novel technique that aims to facilitate the critical step of retrograde wire externalization during reverse controlled antegrade and retrograde tracking and dissection (CART), which we named DRAFT (Deflate, Retract and Advance into the Fenestration Technique).

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. The Glider registry

Gioel Gabrio Secco MD, Harald Rittger MD, Stefan Hoffmann MD, Gert Richardt MD, Mohamed Abdel‐Wahab MD, Holger Reinecke MD, Chaim Lotan MD, Gerald Werner MD, Horst Sievert MD, Nicolas Foin MSC, Carlo Di Mario MD

Background: Provisional stenting of the side‐branch (SB) is the universally accepted gold standard while there is still controversy on the usefulness of routine dilatation of the SB ostium. Recrossing the struts of a previously deployed stent with a wire and a balloon can prove challenging and is occasionally unsuccessful, mainly because the balloon tip hits a stent strut. This prospective multicenter international registry tested the crossing ability procedural results of a new‐dedicated ultrashort balloon specifically designed for side branch dilatation (Glider, TriReme Medical, Pleasanton, CA, USA).

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Severe mitral regurgitation and biventricular heart failure successfully treated with biventricular percutaneous axial flow pumps as a bridge to mitral valve surgery

Brian M. Renard MD, Ivan D. Hanson MD, James A. Goldstein MD

Prompt recognition of acute right ventricular failure is essential in order to provide timely hemodynamic support. We report a case of a patient with severe mitral regurgitation complicated by cardiogenic shock that failed to improve with left ventricular support alone. The recognition of concomitant right ventricular failure led to the addition of a right ventricular support device, resulting in dramatic hemodynamic improvement. © 2016 Wiley Periodicals, Inc.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Sex‐based differences in outcomes with bivalirudin or unfractionated heparin for transcatheter aortic valve replacement: Results from the BRAVO‐3 randomized trial

A. Asgar MD, J. Chandrasekhar MBBS, G. Mikhail MD, J. Webb MD, T. Lefèvre MD, C. Tamburino MD, D. Hildick‐Smith MD, R. Hambrecht MD, E. Van Belle MD, J. Widder MD, N. Dumonteil MD, U Hink MD, R. Jeger MD, A. Linke MD, E. Deliargyris MD, P. Gao MS R. Mehran MD, C. Hengstenberg MD, P. Anthopoulos MD, G. Dangas MD, PhD

Background: Women comprise almost 50% of patients undergoing transcatheter aortic valve replacement (TAVR) and previous studies have indicated higher rates of procedural complications and bleeding in women compared to men. It is unknown whether men and women demonstrate a differential response to bivalirudin versus unfractionated heparin (UFH) in TAVR. We sought to evaluate outcomes by sex and type of anticoagulant from the Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement (BRAVO‐3) trial of transfemoral TAVR.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Mechanical thrombectomy using the Solitaire stent in a left main coronary artery: A novel approach to coronary thrombus retrieval

Carlos E. Uribe MD, Mauricio Zuñiga MD, Camilo Madrid MD

The Solitaire stent is a self‐expanding nitinol, fully retrievable stent that was originally designed for applications in cerebral circulation. Expanded indications for its use in mechanical embolectomy during acute ischemic stroke have proven safe and effective. Herein, we describe a novel use of this stent to perform a mechanical thrombectomy of a large left main coronary artery thrombus.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Spontaneous Coronary Artery Dissection

Sebastian Rogowski MD, Micha T. Maeder MD, Daniel Weilenmann MD, Philipp K. Haager MD, Peter Ammann MD, Franziska Rohner MD, Lucas Joerg MD, Hans Rickli MD

Objective: We sought to assess the angiographic and long‐term clinical outcomes in a predominantly medically treated population with spontaneous coronary artery dissection (SCAD).

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry

Toru Naganuma MD, Antonio Colombo MD, Maciej Lesiak MD, Davide Capodanno MD, PhD, Tommaso Gori MD, PhD, Holger Nef MD, Giuseppe Caramanno MD, Christoph Naber MD, Carlo Di Mario MD, Neil Ruparelia MD, Piera Capranzano MD, Jens Wiebe MD, Aleksander Araszkiewicz MD, Salvatore Geraci MD, Hiroyoshi Kawamoto MD, Stelios Pyxaras MD, Alessio Mattesini MD, Thomas Münzel MD, Corrado Tamburino MD, PhD, Azeem Latib MD

Objectives: The aim of this study was to evaluate midterm outcomes of bioresorbable vascular scaffolds (BVS) implanted in bifurcation lesions.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two‐year follow‐up of the observational, prospective, controlled, and multicenter ERACI IV registry

Carlos Haiek MD, Carlos Fernández‐Pereira MD, PhD, FSCAI, Omar Santaera MD, Juan Mieres MD, Ignacio Rifourcat MD, Juan Lloberas MD, Miguel Larribau MD, Antonio Pocoví MD, Alfredo M. Rodriguez‐Granillo MD, Ricardo A. Sarmiento MD, David Antoniucci MD, FESC, Alfredo E. Rodriguez MD, PhD, FSCAI, FACC

Objective: To compare second generation drug eluting stents (2DES) with first generation (1DES) for the treatment of patients (pts) with multiple coronary vessel disease (MVD).

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Angiographic predictors of 2‐year stent thrombosis in patients receiving drug‐eluting stents: Insights from the ADAPT‐DES study

Philippe Généreux MD, Björn Redfors MD, PhD, Bernhard Witzenbichler MD, Akiko Maehara MD, Mayank Yadav MD, Giora Weisz MD, Dominic P. Francese MPH, Rupa Parvataneni MS, Sorin J. Brener MD, Roxana Mehran MD, Ajay J. Kirtane MD, SM, Gregg W. Stone MD

Objectives: We sought to identify angiographic predictors of 2‐year stent thrombosis (ST) in the ADAPT‐DES study.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Long‐term outcomes following mini‐crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New‐Tokyo (MITO) registry

Hiroyoshi Kawamoto MD, Kensuke Takagi MD, Alaide Chieffo MD, Neil Ruparelia DPHIL, MRCP, Yusuke Fujino MD, PhD, Hiroto Yabushita MD, Yusuke Watanabe MD, Azeem Latib MD, Mauro Carlino MD, Matteo Montorfano MD, Sunao Nakamura MD, PhD, Antonio Colombo MD

Objectives: This study aimed to investigate the long‐term outcomes following mini‐crush versus culotte stenting with drug‐eluting stents (DES) for the treatment of unprotected left main coronary artery (LMCA) disease.

01 enero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Long‐term prognostic value of risk scores after drug‐eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR‐LEFT‐MAIN and ISAR‐LEFT‐MAIN 2 randomized clinical trials

Erion Xhepa MD, Tomohisa Tada MD, Sebastian Kufner MD, Gjin Ndrepepa MD, Robert A. Byrne MB BcH, PhD, Johanna Kreutzer MD, Tareq Ibrahim MD, Klaus Tiroch MD, Marco Valgimigli MD, PhD, Ralf Tölg MD, Salvatore Cassese MD, PhD, Massimiliano Fusaro MD, Heribert Schunkert MD, Karl L. Laugwitz MD, Julinda Mehilli MD, Adnan Kastrati MD

Objectives: To evaluate the long‐term prognostic value of risk scores in the setting of drug‐eluting stent (DES) implantation for uLMCA.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.